Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Revenue (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Revenue over the past 16 years, most recently at $36.4 million for Q2 2025.

  • For Q2 2025, Revenue fell 3.81% year-over-year to $36.4 million; the TTM value through May 2025 reached $128.9 million, changed 0.47%, while the annual FY2025 figure was $128.9 million, 0.47% changed from the prior year.
  • Revenue for Q2 2025 was $36.4 million at Lifecore Biomedical, Inc. \De\, up from $35.2 million in the prior quarter.
  • Over five years, Revenue peaked at $44.9 million in Q2 2021 and troughed at $21.9 million in Q4 2022.
  • A 5-year average of $30.2 million and a median of $29.1 million in 2022 define the central range for Revenue.
  • Biggest five-year swings in Revenue: tumbled 81.82% in 2021 and later soared 37.9% in 2023.
  • Year by year, Revenue stood at $25.6 million in 2021, then dropped by 14.6% to $21.9 million in 2022, then skyrocketed by 37.9% to $30.2 million in 2023, then rose by 8.01% to $32.6 million in 2024, then increased by 11.91% to $36.4 million in 2025.
  • Business Quant data shows Revenue for LFCR at $36.4 million in Q2 2025, $35.2 million in Q1 2025, and $32.6 million in Q4 2024.